Posted by Michael Wonder on 05 Jun 2023
FDA considers temporary cancer drug imports from unapproved companies to ease US shortage
1 June 2023 - Shortages of cisplatin and carboplatin have forced some hospitals to ration the drugs by reducing doses to extend the supply and prioritise patients who would benefit the most from treatment.
The FDA did not say which manufacturers would be potential candidates for permitting temporary importation of those drugs until approved manufacturers are able to meet patients’ needs.
